HDL phospholipid: A natural inhibitor of Alzheimer's amyloid β-fibrillogenesis? [2]

[No abstract available]

Авторы
Koudinov A.R. 3, 1, 2, 4, 6 , Koudinova N.V. 4, 1, 2 , Berezov T.T. 5, 1, 2 , Ivanov Y.D. 1
Журнал
Clinical Chemistry and Laboratory Medicine
Номер выпуска
10
Язык
Английский
Страницы
993-994
Статус
Опубликовано
Ссылка
Внешняя ссылка
Том
37
Год
1999
Организации
  • 1 Institute of Biomedical Chemistry, Moscow, Russian Federation
  • 2 Russian Academy of Medical Sciences, Moscow, Russian Federation
  • 3 Natl. Mental Health Research Center, Moscow, Russian Federation
  • 4 Weizmann Institute, Department of Neurobiology, Rehovot, Israel
  • 5 Department of Biochemistry, Russ. People's Friendship Univ. S., Moscow, Russian Federation
  • 6 Department of Neurobiology, Brain Research Jaglom Bldg., Weizmann Institute of Science, Rehovot 76100, Israel
Ключевые слова
priority journal; amyloid beta protein; apolipoprotein; dimyristoylphosphatidylcholine; high density lipoprotein; phosphatidylcholine; phospholipid; Alzheimer disease; competitive inhibition; human; letter; protein binding; protein cerebrospinal fluid level; protein secondary structure; proteoliposome; Raman spectrometry; solution and solubility; Alzheimer Disease; Amyloid beta-Protein; Circular Dichroism; Dimyristoylphosphatidylcholine; Humans; Lipoproteins, HDL; Neurofibrils; Protein Structure, Secondary; Spectrum Analysis, Raman
Цитировать
ГОСТ MLA RIS BibTex
Поделиться

Другие записи